Why Attend the MASH Drug Development Summit?
Building upon the latest scientific advancements and evolving understanding of MASH pathogenesis and clinical trial progress, this summit dissected the future of MASH drug discovery, development, and clinical application.
What Did You Miss?
Understand
Understand the varying mechanisms of being utilized to develop MASH drugs and unlock the potential of precisely targeted therapies for enhanced efficacy for heterogenous patient populations
Advance
Advance the integration of non-invasive biomarkers into MASH drug development, exploring their utility from early diagnosis to monitoring treatment response, to accelerate development pathways and reduce reliance on invasive procedures
Optimize
Optimize the design of clinical trials for MASH therapies, addressing challenges in patient stratification, endpoint selection, and real-world evidence integration, to accelerate drug approval and ensure robust clinical outcomes
Stand-Out
This is your opportunity to be at the forefront of MASH drug development at this critical endeavor as the therapeutic potential for liver health expands, accelerating the development of life-changing treatments for millions affected globally.
What Was New for 2025?
Learn Cutting-Edge Strategies
for identifying and stratifying MASH patient populations, to account for the disease's heterogeneity and optimize study design for more impactful and successful clinical outcomes
Explore the Latest Advancements in Non-Invasive Diagnostic Tools
including cutting-edge blood-based biomarkers and imaging technologies to provide patient-friendly and more accurate alternatives to traditional liver biopsies to enhance the early detection and accurate disease characterization during MASH diagnosis, prognosis and monitoring
Discuss the Potential for Strategic Design and Practical Implementation
of combination and sequential therapies to develop multifaceted treatment approaches that optimize synergistic effects to effectively address the complex heterogeneity of MASH
Discover Innovative Cell-Specific Drug Delivery Methods
and a diverse range of novel mechanisms of action, including inflammatory modulation, siRNA approaches, and FGF21 signaling to directly deliver therapeutic agents to specific liver cell types to target underlying disease drivers and minimize off-target effects
Gain Insights into the Unique Biological Actions of GLP-1 Receptor Agonists
to review their compelling clinical evidence in MASH and explore their expanded role to identify comprehensive therapeutic avenues for MASH patients
Explore the 2025 Full Event Guide
- 60+ MASH Scientists & Drug Development Experts Sharing Groundbreaking Research & Strategies
- 1 Pre-Conference Combination & Sequential Therapy Day
- 10+ Hours of Networking with 60+ Likeminded MASH-Focused Peers
Attending Companies Include
Explore the 2025 Agenda
Reflect on the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions from last year's summit.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Industry Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.